In the current study, application of the higher D‐dimer cutoff content to predict response to anti‐PD‐1 treatment in NSCLC patients and assess of disease progression validated the association of high D‐dimer content with short duration of PFS. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.